Global and United States Genome Perturbation Tools Market Report & Forecast 2023-2029
Exclusive deal : 20% Instant discount on Direct purchases! Don't wait—claim your discount today!
The research time span covered by the report is from 2018 to 2029; it provides an overview of the Global Genome Perturbation Tools Market and also provides a deeper in-depth segmentation of the market by regions, product type and downstream industries.
The global Genome Perturbation Tools market size in 2022 is 1000.0 million US dollars, and it is expected to be XX million US dollars by 2029, with a compound annual growth rate of 9.50% expected in 2023-2029.
MARKET COMPETITIVE LANDSCAPE:
The main players in the Genome Perturbation Tools market include 10x Genomics (U.S.), Dovetail Genomics (U.S.), Illumina, Inc (U.S.), NanoString (U.S.), and OriGene Technologies, Inc. (U.S.). The share of the top 3 players in the Genome Perturbation Tools market is XX%.
REGION SHARE:
The report covers the market size information of North America, Europe, Asia Pacific, Latin America, Middle East and Africa, and North America accounted for XX%, Europe accounted for XX% of Genome Perturbation Tools market, and Asia Pacific accounted for XX%.
SEGMENT OVERVIEW:
The report segments the market by Type and Application. Automated accounted for XX% of Genome Perturbation Tools market in 2022. Semi-automated share of XX%.
Translational Research accounted for XX% of the Genome Perturbation Tools market in 2022. Academic Customers accounts for XX%.
For competitive landscape, prominent players with considerable market shares are comprehensively analyzed in this report. With information regarding the concentration ratio and detailed data reflecting the market performance of each player shared, the readers can acquire a holistic view of the competitive situation and a better understanding of their competitors.
As the COVID-19 takes over the world, we are continuously tracking the changes in the markets. We analyzed the impact of the pandemic in detail, along with other key factors, such as macro-economy, regional conflicts, industry related news and policies. Meanwhile, market investment scenario, technology status and developments, supply chain challenges, among other essential research elements are all covered.
Key Factors Considered:
COVID-19
The report describes the market scenario during and post the pandemic in the vision of upstream, major market participants, downstream major customers, etc. Other aspects, such as changes in consumer behavior, demand, transport capacity, trade flow under COVID-19, have also been taken into consideration during the process of the research.
Regional Conflict / Russia-Ukraine War
The report also presents the impact of regional conflict on this market in an effort to aid the readers to understand how the market has been adversely influenced and how it's going to evolve in the years to come.
Challenges & Opportunities
Factors that may help create opportunities and boost profits for market players, as well as challenges that may restrain or even pose a threat to the development of the players, are revealed in the report, which can shed a light on strategic decisions and implementation.
The life sciences industry grows and continues to advance, driving innovation and improving healthcare outcomes for individuals around the world.
Artificial Intelligence (AI) and Machine Learning (ML): AI and ML technologies are increasingly being employed in life sciences research and development. They aid in drug discovery, optimizing clinical trials, analyzing vast amounts of biological data, and identifying patterns that can lead to breakthroughs in understanding diseases and developing new therapies.
Digital Health Technologies: Digital health technologies have seen rapid growth, especially in areas like telemedicine, wearable devices, and mobile health applications. These technologies enable remote patient monitoring, facilitate better healthcare access, and empower individuals to manage their health more effectively.
Wearable Devices and Remote Monitoring: Wearable devices, such as smartwatches and fitness trackers, have become more sophisticated, enabling continuous monitoring of vital signs and health parameters. These devices offer opportunities for early detection of health issues and improved management of chronic conditions.
Highlights-Regions
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Asia Pacific
China
Japan
South Korea
India
Southeast Asia
Australia
Latin America
Brazil
Argentina
Mexico
MEA
Saudi Arabia
UAE
Turkey
Player list
10x Genomics (U.S.)
Dovetail Genomics (U.S.)
Illumina, Inc (U.S.)
NanoString (U.S.)
OriGene Technologies, Inc. (U.S.)
Seven Bridges Genomics (U.S.)
Horizon Discovery Ltd. (U.K.)
Advanced Cell Diagnostics, Inc. (U.S.)
Eiken Chemical Co., Ltd. (Japan)
Types list
Automated
Semi-automated
Manual
Application list
Translational Research
Academic Customers
Diagnostic Customers
Pharmaceutical Manufacturer
Table of Content
1 Study Coverage
1.1 Genome Perturbation Tools Product Introduction
1.2 Global Genome Perturbation Tools Outlook 2018 VS 2023 VS 2029
1.3 United States Genome Perturbation Tools Outlook 2018 VS 2023 VS 2029
1.4 Genome Perturbation Tools Market Size, United States VS Global, 2018-2029
1.4.1 The Market Share of United States Genome Perturbation Tools in Global, 2018-2029
1.4.2 The Growth Rate of Genome Perturbation Tools Market Size, United States VS Global, 2018 VS 2023 VS 2029
1.5 Genome Perturbation Tools Market Dynamics
1.5.1 Genome Perturbation Tools Market Trends
1.5.2 Genome Perturbation Tools Market Drivers
1.5.3 Genome Perturbation Tools Market Challenges
1.5.4 Genome Perturbation Tools Market Restraints
1.6 Study Objectives
1.7 Years Considered
1.8 Coronavirus Disease (COVID-19) Impact on Global
2 Global Genome Perturbation Tools Competitor Landscape by Company
2.1 Global Genome Perturbation Tools Market Size by Company
2.1.1 Top Global Genome Perturbation Tools Player Ranked by Revenue (2023)
2.1.2 Global Genome Perturbation Tools Revenue by Player (2018-2023)
2.2 Global Genome Perturbation Tools Concentration Ratio (CR)
2.2.1 Genome Perturbation Tools Market Concentration Ratio (CR) (2018-2023)
2.2.2 Global Top 3 and Top 6 Largest Players of Genome Perturbation Tools in 2023
2.3 Global Genome Perturbation Tools Business Distribution, Business Type
2.3.1 Global Genome Perturbation Tools Players, Headquarters and Distribution
2.3.2 Players Genome Perturbation Tools Business Type
2.3.3 Date of International Players Enter into Genome Perturbation Tools Market
2.4 Players Mergers & Acquisitions, Expansion Plans
2.5 United States Genome Perturbation Tools Market Size by Company
2.5.1 Top United States Genome Perturbation Tools Player s Ranked by Revenue (2023)
2.5.2 United States Genome Perturbation Tools Revenue by Player (2018-2023)
3 Genome Perturbation Tools Market Segment by Type
3.1 Genome Perturbation Tools Market Segment by Type
3.2 Global Genome Perturbation Tools Market Size by Type
3.3 United States Genome Perturbation Tools Market Size by Type
4 Genome Perturbation Tools by Market Segment Application
4.1 Genome Perturbation Tools Market Segment by Application
4.2 Global Genome Perturbation Tools Market Size by Application
4.3 United States Genome Perturbation Tools Market Size by Application
5 Global Genome Perturbation Tools Market Size by Region
5.1 Global Genome Perturbation Tools Market Size by Region: 2018 VS 2023 VS 2029
5.2 Global Genome Perturbation Tools Market Size in Value by Region (2018-2029)
5.2.1 Global Genome Perturbation Tools Revenue by Region: 2018-2023
5.2.2 Global Genome Perturbation Tools Revenue by Region: 2023-2029
6 Segment in Regional Level & Country Level
6.1 North America
6.1.1 North America Genome Perturbation Tools Market Size YoY Growth 2018-2029
6.1.2 North America Genome Perturbation Tools Market Facts & Figures by Country (2018-2029)
6.1.3 U.S.
6.1.4 Canada
6.2 Asia Pacific
6.2.1 Asia Pacific Genome Perturbation Tools Market Size YoY Growth 2018-2029
6.2.2 Asia Pacific Genome Perturbation Tools Market Facts & Figures by Country (2018-2029)
6.2.3 China
6.2.4 Japan
6.2.5 South Korea
6.2.6 India
6.2.7 Australia
6.2.8 Southeast Asia
6.3 Europe
6.3.1 Europe Genome Perturbation Tools Market Size YoY Growth 2018-2029
6.3.2 Europe Genome Perturbation Tools Market Facts & Figures by Country (2018-2029)
6.3.3 Germany
6.3.4 France
6.3.5 UK
6.3.6 Italy
6.3.7 Russia
6.4 Latin America
6.4.1 Latin America Genome Perturbation Tools Market Size YoY Growth 2018-2029
6.4.2 Latin America Genome Perturbation Tools Market Facts & Figures by Country (2018-2029)
6.4.3 Mexico
6.4.4 Brazil
6.4.5 Argentina
6.5 Middle East and Africa
6.5.1 Middle East and Africa Genome Perturbation Tools Market Size YoY Growth 2018-2029
6.5.2 Middle East and Africa Genome Perturbation Tools Market Facts & Figures by Country (2018-2029)
6.5.3 Turkey
6.5.4 Saudi Arabia
6.5.5 UAE
7 Company Profiles
7.1 10x Genomics (U.S.)
7.1.1 Company Details
7.1.2 Description and Business Overview
7.1.3 Genome Perturbation Tools Introduction
7.1.4 10x Genomics (U.S.) Genome Perturbation Tools Revenue, Gross, and Gross Margin (2018-2023)
7.1.5 10x Genomics (U.S.) Recent Development
7.2 Dovetail Genomics (U.S.)
7.2.1 Company Details
7.2.2 Description and Business Overview
7.2.3 Genome Perturbation Tools Introduction
7.2.4 Dovetail Genomics (U.S.) Genome Perturbation Tools Revenue, Gross, and Gross Margin (2018-2023)
7.2.5 Dovetail Genomics (U.S.) Recent Development
7.3 Illumina, Inc (U.S.)
7.3.1 Company Details
7.3.2 Description and Business Overview
7.3.3 Genome Perturbation Tools Introduction
7.3.4 Illumina, Inc (U.S.) Genome Perturbation Tools Revenue, Gross, and Gross Margin (2018-2023)
7.3.5 Illumina, Inc (U.S.) Recent Development
7.4 NanoString (U.S.)
7.4.1 Company Details
7.4.2 Description and Business Overview
7.4.3 Genome Perturbation Tools Introduction
7.4.4 NanoString (U.S.) Genome Perturbation Tools Revenue, Gross, and Gross Margin (2018-2023)
7.4.5 NanoString (U.S.) Recent Development
7.5 OriGene Technologies, Inc. (U.S.)
7.5.1 Company Details
7.5.2 Description and Business Overview
7.5.3 Genome Perturbation Tools Introduction
7.5.4 OriGene Technologies, Inc. (U.S.) Genome Perturbation Tools Revenue, Gross, and Gross Margin (2018-2023)
7.5.5 OriGene Technologies, Inc. (U.S.) Recent Development
7.6 Seven Bridges Genomics (U.S.)
7.6.1 Company Details
7.6.2 Description and Business Overview
7.6.3 Genome Perturbation Tools Introduction
7.6.4 Seven Bridges Genomics (U.S.) Genome Perturbation Tools Revenue, Gross, and Gross Margin (2018-2023)
7.6.5 Seven Bridges Genomics (U.S.) Recent Development
7.7 Horizon Discovery Ltd. (U.K.)
7.7.1 Company Details
7.7.2 Description and Business Overview
7.7.3 Genome Perturbation Tools Introduction
7.7.4 Horizon Discovery Ltd. (U.K.) Genome Perturbation Tools Revenue, Gross, and Gross Margin (2018-2023)
7.7.5 Horizon Discovery Ltd. (U.K.) Recent Development
7.8 Advanced Cell Diagnostics, Inc. (U.S.)
7.8.1 Company Details
7.8.2 Description and Business Overview
7.8.3 Genome Perturbation Tools Introduction
7.8.4 Advanced Cell Diagnostics, Inc. (U.S.) Genome Perturbation Tools Revenue, Gross, and Gross Margin (2018-2023)
7.8.5 Advanced Cell Diagnostics, Inc. (U.S.) Recent Development
7.9 Eiken Chemical Co., Ltd. (Japan)
7.9.1 Company Details
7.9.2 Description and Business Overview
7.9.3 Genome Perturbation Tools Introduction
7.9.4 Eiken Chemical Co., Ltd. (Japan) Genome Perturbation Tools Revenue, Gross, and Gross Margin (2018-2023)
7.9.5 Eiken Chemical Co., Ltd. (Japan) Recent Development
8 Value Chain and Sales Channels Analysis
8.1 Genome Perturbation Tools Value Chain Analysis
8.2 Genome Perturbation Tools Customers
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology
10.1.1 Research Process
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Legal Disclaimer
Tables & Figures:
List of Tables and Figures
Figure Genome Perturbation Tools Product Picture
Table Global Genome Perturbation Tools Revenue, ($), 2018 VS 2023 VS 2029
Figure Global Genome Perturbation Tools Market Size 2018-2029 ($)
Table United States Genome Perturbation Tools Revenue, ($), 2018 VS 2023 VS 2029
Figure United States Genome Perturbation Tools Market Size 2018-2029 ($)
Figure United States Genome Perturbation Tools Market Share in Global, in Value 2018-2029
Table Genome Perturbation Tools CAGR in Value, United States VS Global, 2018 VS 2023 VS 2029
Table Genome Perturbation Tools Market Trends
Table Genome Perturbation Tools Market Drivers
Table Genome Perturbation Tools Market Challenges
Table Genome Perturbation Tools Market Restraints
Figure Genome Perturbation Tools Report Years Considered
Figure (COVID-19) Impact on Global Economic Growth 2019, 2020, 2021
Figure Population infected by the Covid-19 of Major Countries
Table Top Genome Perturbation Tools Players in Global Market, Ranking by Revenue (2023)
Table Global Genome Perturbation Tools Revenue by Player, ($), 2018-2023
Table Global Genome Perturbation Tools Revenue Share by Player, 2018-2023
Table Global Genome Perturbation Tools Players Market Concentration Ratio (CR5)
Figure The Top 3 and 6 Largest Players of Genome Perturbation Tools in the World: Market Share by Genome Perturbation Tools Revenue in 2023
Table Top Players of Genome Perturbation Tools in Global Market, Headquarters and Distribution
Table Players Genome Perturbation Tools Business Type
Table Date of International Players Enter into Genome Perturbation Tools Market
Table Players Mergers & Acquisitions, Expansion Plans
Table Top Genome Perturbation Tools Players in United States Market, Ranking by Revenue (2023)
Table United States Genome Perturbation Tools Revenue by Player, ($), 2018-2023
Table United States Genome Perturbation Tools Revenue Share by Player, 2018-2023
Table Global Genome Perturbation Tools Revenue by Type: 2023 VS 2029 ($)
Figure Global Genome Perturbation Tools Market Share by Type in 2023 & 2029
Figure Global Genome Perturbation Tools Revenue by Type (2018-2029) & ($)
Figure Global Genome Perturbation Tools Revenue Market Share in Value by Type (2018-2029)
Table United States Genome Perturbation Tools Revenue by Type: 2023 VS 2029 ($)
Figure United States Genome Perturbation Tools Market Share by Type in 2023 & 2029
Figure United States Genome Perturbation Tools Revenue by Type (2018-2029) & ($)
Figure United States Genome Perturbation Tools Revenue Market Share in Value by Type (2018-2029)
Table Global Genome Perturbation Tools Revenue by Application: 2023 VS 2029 ($)
Figure Global Genome Perturbation Tools Market Share by Application in 2023 & 2029
Figure Global Genome Perturbation Tools Revenue by Application (2018-2029) & ($)
Figure Global Genome Perturbation Tools Revenue Market Share in Value by Application (2018-2029)
Table United States Genome Perturbation Tools Revenue by Application: 2023 VS 2029 ($)
Figure United States Genome Perturbation Tools Market Share by Application in 2023 & 2029
Figure United States Genome Perturbation Tools Revenue by Application (2018-2029) & ($)
Figure United States Genome Perturbation Tools Revenue Market Share in Value by Application (2018-2029)
Table Global Genome Perturbation Tools Market Size by Region ($): 2018 VS 2023 VS 2029
Figure Global Genome Perturbation Tools Market Size Market Share by Region: 2018 VS 2023 VS 2029
Table Global Genome Perturbation Tools Revenue by Region (2018-2023) & ($)
Table Global Genome Perturbation Tools Revenue Forecast by Region (2023-2029) & ($)
Table Global Genome Perturbation Tools Revenue Market Share by Region (2018-2029)
Figure North America Genome Perturbation Tools Revenue Growth Rate 2018-2029
Table North America Genome Perturbation Tools Revenue by Country (2018-2029) & ($)
Figure U.S. Genome Perturbation Tools Revenue Growth Rate (2018-2029) & ($)
Figure Canada Genome Perturbation Tools Revenue Growth Rate (2018-2029) & ($)
Figure Asia Pacific Genome Perturbation Tools Revenue Growth Rate 2018-2029 ($)
Table Asia Pacific Genome Perturbation Tools Revenue by Country (2018-2029) & ($)
Figure China Genome Perturbation Tools Revenue Growth Rate (2018-2029) & ($)
Figure Japan Genome Perturbation Tools Revenue Growth Rate (2018-2029) & ($)
Figure South Korea Genome Perturbation Tools Revenue Growth Rate (2018-2029) & ($)
Figure India Genome Perturbation Tools Revenue Growth Rate (2018-2029) & ($)
Figure Australia Genome Perturbation Tools Revenue Growth Rate (2018-2029) & ($)
Figure Southeast Asia Genome Perturbation Tools Revenue Growth Rate (2018-2029) & ($)
Figure Europe Genome Perturbation Tools Revenue Growth Rate 2018-2029 ($)
Table Europe Genome Perturbation Tools Revenue by Country (2018-2029) & ($)
Figure Germany Genome Perturbation Tools Revenue Growth Rate (2018-2029) & ($)
Figure France Genome Perturbation Tools Revenue Growth Rate (2018-2029) & ($)
Figure UK Genome Perturbation Tools Revenue Growth Rate (2018-2029) & ($)
Figure Italy Genome Perturbation Tools Revenue Growth Rate (2018-2029) & ($)
Figure Russia Genome Perturbation Tools Revenue Growth Rate (2018-2029) & ($)
Figure Latin America Genome Perturbation Tools Revenue Growth Rate 2018-2029 ($)
Table Latin America Genome Perturbation Tools Revenue by Country (2018-2029) & ($)
Figure Mexico Genome Perturbation Tools Revenue Growth Rate (2018-2029) & ($)
Figure Brazil Genome Perturbation Tools Revenue Growth Rate (2018-2029) & ($)
Figure Argentina Genome Perturbation Tools Revenue Growth Rate (2018-2029) & ($)
Figure Middle East and Africa Genome Perturbation Tools Revenue Growth Rate 2018-2029 ($)
Table Middle East and Africa Genome Perturbation Tools Revenue by Country (2018-2029) & ($)
Figure Turkey Genome Perturbation Tools Revenue Growth Rate (2018-2029) & ($)
Figure Saudi Arabia Genome Perturbation Tools Revenue Growth Rate (2018-2029) & ($)
Figure UAE Genome Perturbation Tools Revenue Growth Rate (2018-2029) & ($)
Table 10x Genomics (U.S.) Company Details
Table Description and Business Overview
Table Genome Perturbation Tools Introduction
Table 10x Genomics (U.S.) Genome Perturbation Tools Revenue, Gross, and Gross Margin (2018-2023) (Million USD)
Table 10x Genomics (U.S.) Recent Development
Table Dovetail Genomics (U.S.) Company Details
Table Description and Business Overview
Table Genome Perturbation Tools Introduction
Table Dovetail Genomics (U.S.) Genome Perturbation Tools Revenue, Gross, and Gross Margin (2018-2023) (Million USD)
Table Dovetail Genomics (U.S.) Recent Development
Table Illumina, Inc (U.S.) Company Details
Table Description and Business Overview
Table Genome Perturbation Tools Introduction
Table Illumina, Inc (U.S.) Genome Perturbation Tools Revenue, Gross, and Gross Margin (2018-2023) (Million USD)
Table Illumina, Inc (U.S.) Recent Development
Table NanoString (U.S.) Company Details
Table Description and Business Overview
Table Genome Perturbation Tools Introduction
Table NanoString (U.S.) Genome Perturbation Tools Revenue, Gross, and Gross Margin (2018-2023) (Million USD)
Table NanoString (U.S.) Recent Development
Table OriGene Technologies, Inc. (U.S.) Company Details
Table Description and Business Overview
Table Genome Perturbation Tools Introduction
Table OriGene Technologies, Inc. (U.S.) Genome Perturbation Tools Revenue, Gross, and Gross Margin (2018-2023) (Million USD)
Table OriGene Technologies, Inc. (U.S.) Recent Development
Table Seven Bridges Genomics (U.S.) Company Details
Table Description and Business Overview
Table Genome Perturbation Tools Introduction
Table Seven Bridges Genomics (U.S.) Genome Perturbation Tools Revenue, Gross, and Gross Margin (2018-2023) (Million USD)
Table Seven Bridges Genomics (U.S.) Recent Development
Table Horizon Discovery Ltd. (U.K.) Company Details
Table Description and Business Overview
Table Genome Perturbation Tools Introduction
Table Horizon Discovery Ltd. (U.K.) Genome Perturbation Tools Revenue, Gross, and Gross Margin (2018-2023) (Million USD)
Table Horizon Discovery Ltd. (U.K.) Recent Development
Table Advanced Cell Diagnostics, Inc. (U.S.) Company Details
Table Description and Business Overview
Table Genome Perturbation Tools Introduction
Table Advanced Cell Diagnostics, Inc. (U.S.) Genome Perturbation Tools Revenue, Gross, and Gross Margin (2018-2023) (Million USD)
Table Advanced Cell Diagnostics, Inc. (U.S.) Recent Development
Table Eiken Chemical Co., Ltd. (Japan) Company Details
Table Description and Business Overview
Table Genome Perturbation Tools Introduction
Table Eiken Chemical Co., Ltd. (Japan) Genome Perturbation Tools Revenue, Gross, and Gross Margin (2018-2023) (Million USD)
Table Eiken Chemical Co., Ltd. (Japan) Recent Development
Figure Genome Perturbation Tools Value Chain
Table Major Customers of Genome Perturbation Tools with Contact Information
Table Research Process
Figure Bottom-up and Top-down Approaches for This Report
Research Methodology:
Global and United States Genome Perturbation Tools Market Size Estimation
To estimate market size and trends, we use a combination of top-down and bottom-up methods. This allows us to evaluate the market from various perspectives—by company, region, product type, and end users.
Our estimates are based on actual sales data, excluding any discounts. Segment breakdowns and market shares are calculated using weighted averages based on usage rates and average prices. Regional insights are determined by how widely a product or service is adopted in each area.
Key companies are identified through secondary sources like industry reports and company filings. We then verify revenue estimates and other key data points through primary research, including interviews with industry experts, company executives, and decision-makers.
We take into account all relevant factors that could influence the market and validate our findings with real-world input. Our final insights combine both qualitative and quantitative data to provide a well-rounded view. Please note, these estimates do not account for unexpected changes such as inflation, economic downturns, or policy shifts.
Data Source
Secondary Sources
This study draws on a wide range of secondary sources, including press releases, annual reports, non-profit organizations, industry associations, government agencies, and customs data. We also referred to reputable databases and directories such as Bloomberg, Wind Info, Hoovers, Factiva, Trading Economics, Statista, and others. Additional references include investor presentations, company filings (e.g., SEC), economic data, and documents from regulatory and industry bodies.
These sources were used to gather technical and market-focused insights, identify key players, analyze market segmentation and classification, and track major trends and developments across industries.
| Market Size |
|
|
| Market Position of Top Company |
|
|
| Qualitative Analysis |
|
|
Primary Sources
As part of our primary research, we interviewed a variety of stakeholders from both the supply and demand sides to gather valuable qualitative and quantitative insights.
On the supply side, we spoke with product manufacturers, competitors, industry experts, research institutions, distributors, traders, and raw material suppliers. On the demand side, we engaged with business leaders, marketing and sales heads, technology and innovation directors, supply chain executives, and end users across key organizations.
These conversations helped us better understand market segmentation, pricing, applications, leading players, supply chains, demand trends, industry outlook, and key market dynamics—including risks, opportunities, barriers, and strategic developments.
Key Data Information from Primary Sources
| Primary Sources | Parameters | Key Data |
| Market Segments(by Application, by Type) |
|
|
| Total Market |
|
|